{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:21:22Z","timestamp":1788546082224,"version":"build-2803163510"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Azrieli Faculty Fellowship"},{"name":"Joan and Irwin Jacobs fellowship"},{"DOI":"10.13039\/100019099","name":"Neubauer Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1543\/21"],"award-info":[{"award-number":["1543\/21"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["2511\/19"],"award-info":[{"award-number":["2511\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","award":["22-110-PG"],"award-info":[{"award-number":["22-110-PG"]}],"id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Synthetic lethality represents a promising therapeutic approach in precision oncology, yet systematic identification of clinically relevant synthetic lethal interactions remains challenging. Here, we present SLAYER (Synthetic Lethality AnalYsis for Enhanced taRgeted therapy), a computational framework that integrates cancer genomic data and genome-wide CRISPR knockout screens to identify potential synthetic lethal interactions. SLAYER employs parallel analytical approaches examining both direct mutation-dependency associations and pathway-mediated relationships across 1080 cancer cell lines. Our integrative method identified 682 putative interactions, which were refined to 148 high-confidence candidates through stringent filtering for effect size, druggability, and clinical prevalence. Systematic validation against protein interaction databases revealed an \u223c14-fold enrichment of known associations among SLAYER predictions compared with random gene pairs. Through pathway-level analysis, we identified inhibition of the aryl hydrocarbon receptor (AhR) as potentially synthetically lethal with RB1 mutations in bladder cancer. Experimental studies demonstrated selective sensitivity to AhR inhibition in RB1-mutant versus wild-type bladder cancer cells, which probably operates through indirect pathway-mediated mechanisms rather than direct genetic interaction. In summary, by integrating mutation profiles, gene dependencies, and pathway relationships, our approach provides a resource for investigating genetic vulnerabilities across cancer types.<\/jats:p>","DOI":"10.1093\/nargab\/lqaf052","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:44:59Z","timestamp":1744868699000},"source":"Crossref","is-referenced-by-count":3,"title":["SLAYER: a computational framework for identifying synthetic lethal interactions through integrated analysis of cancer dependencies"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9847-6623","authenticated-orcid":false,"given":"Ziv","family":"Cohen","sequence":"first","affiliation":[{"name":"The Taub Faculty of Computer Science, Technion\u2014Israel Institute of Technology , Haifa 3200003 ,","place":["Israel"]},{"name":"Faculty of Biology, Technion\u2014Israel Institute of Technology , Haifa 3200003 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Petrenko","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Technion\u2014Israel Institute of Technology , Haifa 3200003 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma\u00a0Sophia","family":"Barisaac","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Technion\u2014Israel Institute of Technology , Haifa 3200003 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas\u00a0R","family":"Abu-Zhayia","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Technion\u2014Israel Institute of Technology , Haifa 3200003 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yanovich-Ben-Uriel","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Technion\u2014Israel Institute of Technology , Haifa 3200003 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9549-9929","authenticated-orcid":false,"given":"Nabieh","family":"Ayoub","sequence":"additional","affiliation":[{"name":"Faculty of Biology, Technion\u2014Israel Institute of Technology , Haifa 3200003 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6334-5039","authenticated-orcid":false,"given":"Dvir","family":"Aran","sequence":"additional","affiliation":[{"name":"The Taub Faculty of Computer Science, Technion\u2014Israel Institute of Technology , Haifa 3200003 ,","place":["Israel"]},{"name":"Faculty of Biology, Technion\u2014Israel Institute of Technology , Haifa 3200003 ,","place":["Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"2025042406422199800_B1","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1038\/s41467-018-04647-1","article-title":"Harnessing synthetic lethality to predict the response to cancer treatment","volume":"9","author":"Lee","year":"2018","journal-title":"Nat Commun"},{"key":"2025042406422199800_B2","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.1056072","article-title":"Principles for the buffering of genetic variation","volume":"291","author":"Hartman","year":"2001","journal-title":"Science"},{"key":"2025042406422199800_B3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"2025042406422199800_B4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13045-021-01169-0","article-title":"Targeting mutant p53 for cancer therapy: direct and indirect strategies","volume":"14","author":"Hu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"2025042406422199800_B5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nrg2085","article-title":"Exploring genetic interactions and networks with yeast","volume":"8","author":"Boone","year":"2007","journal-title":"Nat Rev Genet"},{"key":"2025042406422199800_B6","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.cell.2014.07.027","article-title":"Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality","volume":"158","author":"Jerby-Arnon","year":"2014","journal-title":"Cell"},{"key":"2025042406422199800_B7","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-019-1102-x","article-title":"WRN helicase is a synthetic lethal target in microsatellite unstable cancers","volume":"568","author":"Chan","year":"2019","journal-title":"Nature"},{"key":"2025042406422199800_B8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-021-01405-8","article-title":"Uncovering cancer vulnerabilities by machine learning prediction of synthetic lethality","volume":"20","author":"Benfatto","year":"2021","journal-title":"Mol Cancer"},{"key":"2025042406422199800_B9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","article-title":"Prioritization of cancer therapeutic targets using CRISPR\u2013Cas9 screens","volume":"568","author":"Behan","year":"2019","journal-title":"Nature"},{"key":"2025042406422199800_B10","doi-asserted-by":"publisher","first-page":"12671","DOI":"10.1038\/s41598-018-31048-7","article-title":"Inhibition of the glutaredoxin and thioredoxin systems and ribonucleotide reductase by mutant p53-targeting compound APR-246","volume":"8","author":"Haffo","year":"2018","journal-title":"Sci Rep"},{"key":"2025042406422199800_B11","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1002\/ijc.22198","article-title":"Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics","volume":"119","author":"Chen","year":"2006","journal-title":"Int J Cancer"},{"key":"2025042406422199800_B12","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1038\/onc.2010.343","article-title":"Status of p53 in human cancer cells does not predict efficacy of CHK1 kinase inhibitors combined with chemotherapeutic agents","volume":"29","author":"Zenvirt","year":"2010","journal-title":"Oncogene"},{"key":"2025042406422199800_B13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1349-7006.2012.02280.x","article-title":"Novel regulation of checkpoint kinase 1: is checkpoint kinase 1 a good candidate for anti-cancer therapy?","volume":"103","author":"Goto","year":"2012","journal-title":"Cancer Sci"},{"key":"2025042406422199800_B14","doi-asserted-by":"crossref","first-page":"22408","DOI":"10.1074\/jbc.M112.357301","article-title":"Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) activity by small molecule GMX1778 regulates reactive oxygen species (ROS)-mediated cytotoxicity in a p53- and nicotinic acid phosphoribosyltransferase1 (NAPRT1)-dependent manner","volume":"287","author":"Cerna","year":"2012","journal-title":"J Biol Chem"},{"key":"2025042406422199800_B15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1158\/2159-8290.CD-18-1448","article-title":"Drugging RB1 deficiency: synthetic lethality with aurora kinases","volume":"9","author":"Dick","year":"2019","journal-title":"Cancer Disc"},{"key":"2025042406422199800_B16","doi-asserted-by":"publisher","first-page":"37352","DOI":"10.18632\/oncotarget.26424","article-title":"CDK4\/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibition","volume":"9","author":"Gopalan","year":"2018","journal-title":"Oncotarget"},{"key":"2025042406422199800_B17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nmeth.4225","article-title":"Combinatorial CRISPR\u2013Cas9 screens for de novo mapping of genetic interactions","volume":"14","author":"Shen","year":"2017","journal-title":"Nat Methods"},{"key":"2025042406422199800_B18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cell.2018.06.010","article-title":"Mapping the genetic landscape of human cells","volume":"174","author":"Horlbeck","year":"2018","journal-title":"Cell"},{"key":"2025042406422199800_B19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1074\/mcp.M115.053199","article-title":"Systematic prioritization of druggable mutations in \u223c5000 genomes across 16 cancer types using a structural genomics-based approach","volume":"15","author":"Zhao","year":"2016","journal-title":"Mol Cell Proteomics"}],"container-title":["NAR Genomics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nargab\/article-pdf\/7\/2\/lqaf052\/62997178\/lqaf052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nargab\/article-pdf\/7\/2\/lqaf052\/62997178\/lqaf052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T06:43:32Z","timestamp":1745477012000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nargab\/article\/doi\/10.1093\/nargab\/lqaf052\/8118977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3,29]]}},"URL":"https:\/\/doi.org\/10.1093\/nargab\/lqaf052","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.01.592073","asserted-by":"object"}]},"ISSN":["2631-9268"],"issn-type":[{"value":"2631-9268","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,3,29]]},"article-number":"lqaf052"}}